Cargando…
P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430896/ http://dx.doi.org/10.1097/01.HS9.0000970460.94543.ab |
| _version_ | 1785091069224943616 |
|---|---|
| author | Magen, Hila Fried, Shalev Itzhaki, Orit Shem-Tov, Noga Danylesko, Ivetta Yerushalmi, Ronit Shouval, Roni Marcus, Ronit Nevo, Lee Shapira-Frommer, Ronnie Nagler, Arnon Shimoni, Avichai Shkury, Eden Abraham, Avigdor |
| author_facet | Magen, Hila Fried, Shalev Itzhaki, Orit Shem-Tov, Noga Danylesko, Ivetta Yerushalmi, Ronit Shouval, Roni Marcus, Ronit Nevo, Lee Shapira-Frommer, Ronnie Nagler, Arnon Shimoni, Avichai Shkury, Eden Abraham, Avigdor |
| author_sort | Magen, Hila |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430896 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104308962023-08-17 P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA Magen, Hila Fried, Shalev Itzhaki, Orit Shem-Tov, Noga Danylesko, Ivetta Yerushalmi, Ronit Shouval, Roni Marcus, Ronit Nevo, Lee Shapira-Frommer, Ronnie Nagler, Arnon Shimoni, Avichai Shkury, Eden Abraham, Avigdor Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430896/ http://dx.doi.org/10.1097/01.HS9.0000970460.94543.ab Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Magen, Hila Fried, Shalev Itzhaki, Orit Shem-Tov, Noga Danylesko, Ivetta Yerushalmi, Ronit Shouval, Roni Marcus, Ronit Nevo, Lee Shapira-Frommer, Ronnie Nagler, Arnon Shimoni, Avichai Shkury, Eden Abraham, Avigdor P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA |
| title | P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA |
| title_full | P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA |
| title_short | P889: POINT-OF-CARE ANTI-BCMA CAR T-CELL THERAPY INDUCES ENCOURAGING RESPONSE RATES IN HIGH-RISK RELAPSE/REFRACTORY MULTIPLE MYELOMA |
| title_sort | p889: point-of-care anti-bcma car t-cell therapy induces encouraging response rates in high-risk relapse/refractory multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430896/ http://dx.doi.org/10.1097/01.HS9.0000970460.94543.ab |
| work_keys_str_mv | AT magenhila p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT friedshalev p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT itzhakiorit p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT shemtovnoga p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT danyleskoivetta p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT yerushalmironit p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT shouvalroni p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT marcusronit p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT nevolee p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT shapirafrommerronnie p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT naglerarnon p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT shimoniavichai p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT shkuryeden p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma AT abrahamavigdor p889pointofcareantibcmacartcelltherapyinducesencouragingresponseratesinhighriskrelapserefractorymultiplemyeloma |